Ketamine is an innovative, cutting-edge edge and effective psychedelic treatment for severe and debilitating depression.  It has also been shown to be effective for the management of other conditions including trauma related post-traumatic stress disorder (PTSD), addiction, obsessive compulsive disorder (OCD), and certain pain disorders. The therapeutic effects from ketamine can be almost immediate, which makes this a unique treatment in the field of psychiatry.

It’s been shown that the most effective route of administration for ketamine is through intravenous infusion. Spravato (esketamine) is the nasal spray form of Ketamine. For now, Spravato is the only formulation that is FDA-approved and covered by health insurances.

You may benefit from taking Spravato with or without an oral antidepressant if you’re an adult with clinical depression who has had an inadequate response to two or more antidepressants, known as treatment-resistant depression. Spravato is also indicated if you have depression with suicidal ideation or behavior.